Vaxelis 0.5 ml, Injektionssuspension
7680669400033
CH-66940
Injektionssuspension
Associated product:
VAXELIS susp inj avec 1 aiguille 10 ser pré 0.5 ml
1 / 3
google
Article details
- Package size
- 10
- Selling units
- 10
- Measure
- Fertigspritze(n)
- Galenic form
- Injektionssuspension
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
polysaccharida haemophili influenzae typus B conjugata cum proteino neisseriae meningitidis B
|
53.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida haemophili influenzae typus B
|
3.0 UG | Substance | WIIS |
|
neisseria meningitidis B outer membrane protein complex
|
50.0 UG | Substance | WIIS |
|
hepatitidis B viri antigenum ADNr
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
toxoidum pertussis
|
20.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum filamentosum
|
20.0 UG | Substance | Wirkstoff (Principe actif) |
|
pertactinum
|
3.0 UG | Substance | Wirkstoff (Principe actif) |
|
fimbriae
|
5.0 UG | Substance | Wirkstoff (Principe actif) |
|
toxoidum diphtheriae
|
- | Substance | Wirkstoff (Principe actif) |
|
toxoidum tetani
|
- | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 1 inactivatus
|
29.0 U | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 2 inactivatus
|
7.0 U | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 3 inactivatus
|
26.0 U | Substance | Wirkstoff (Principe actif) |
|
aluminium
|
- | Substance | HIMDK |
|
aluminii phosphas
|
- | Substance | HNIDK |
|
aluminii hydroxyphosphas sulfas amorphus
|
- | Substance | HNIDK |
|
natrii phosphates
|
- | Substance | HNIDK |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
1.95 MG | Substance | HBESI |
|
glutaralum
|
- | Substance | RESI |
|
formaldehydum
|
- | Substance | RESI |
|
neomycinum
|
- | Substance | RESI |
|
streptomycinum
|
- | Substance | RESI |
|
polymyxinum B
|
- | Substance | RESI |
|
albuminum seri bovis
|
- | Substance | RESI |
|
aluminii thiocyanas
|
- | Substance | RESI |
|
faecis proteina
|
- | Substance | RESI |
Authorization holder
Future Health Pharma GmbH
8620 Wetzikon ZH
Authorization information
- Swissmedic authorization number
- 66940
- Drug name
- Vaxelis, Injektionssuspension
- Galenic form
- SUPA
- ATC Code
- J07CA09
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 28/08/2019
- Authorization expiration date
- 31/12/9999
- IT Number
- 08.08.
- Domain
- Human medicine
Package details
- Description (FR)
- VAXELIS susp inj avec 1 aiguille 10 ser pré 0.5 ml
- Description (DE)
- VAXELIS Inj Susp mit 1 Nadel 10 Fertspr 0.5 ml
- Market launch
- 28/08/2019
- Narcotic (BTM)
- No